Propanc Biopharma, Inc. (PPCB)
0.095
-0.01
(-5.94%)
USD |
NASDAQ |
May 07, 16:00
0.094
0.00 (0.00%)
After-Hours: 07:03
Propanc Biopharma EPS Diluted (Quarterly) : -0.3012 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lumos Diagnostics Holdings Ltd. | -- |
| Incannex Healthcare, Inc. | -0.5598 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.091M |
| Total Expenses (Quarterly) | 3.091M |
| Enterprise Value | 2.690M |
| Earnings Yield | -14.26K% |
| Normalized Earnings Yield | -14178.42 |